Bugünkü hisse fiyatı Abiomed (ABMD)

Abiomed is a large manufacturer of medical devices for implantation, including artificial hearts, AbioCor and Impella. It was founded in the USA in 1981 as an applied biomedical corporation and worked on the development of an artificial heart. In 2005, it takes over the German company Impella CardioSystems AG. Company

Abiomed posted $ 445.3 million in fiscal year 2017, while earnings per share were $ 1.17 per year. The company is also actively involved in a program to help recruit war veterans in the medical field.